Recent News Goldman Sachs Analysts Predict Massive Surge for Eli Lilly as Growth Trajectory Accelerates The pharmaceutical landscape is witnessing a significant shift as Eli Lilly and Company continues to solidify its position as a dominant force by Josh Weiner 3 hours ago